학술논문
PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 09-10 (2022)
Subject
Language
English
ISSN
2572-9241